Newsletter | July 2, 2025

07.02.25 -- Scaling Up Manufacturing? Here's Why You Need A CMC Specialist

SPONSOR

Webinar: Solving the Inhalation Puzzle: A CDMO's Guide to Dry Powder Development

Dry powders for inhalation (DPIs) represent a versatile delivery platform. However, there are key factors such as required dosage and desired release profiles that dictate the development approach for DPIs. Join Lonza for a webinar that will highlight the key aspects in the product development of inhalation and nasal dry powder products from a CDMO perspective. Click here to learn more.

FEATURED ARTICLES

Formulation Development Of A JAK1 Inhibitor Extended-Release Tablet

This scientific article presents a summary of the formulation development strategy of a JAK1 inhibitor extended-release tablet, with a focus on experimental design, data interpretation, and formulation decision-making.

INDUSTRY INSIGHTS

The Role Of A Consulting Firm In The IND Process

Navigate the complex IND process with expert guidance and discover how early FDA engagement can accelerate your path to clinical trials.

Novel Applications In Pharmaceutical Spray Drying

Whether working with small-scale formulations or preparing for commercial manufacturing, this session will provide actionable strategies to optimize development pipelines.

Helping Deliver A Patient-Centric Future For OSD Manufacturing

Drug developers and manufacturers must address several key challenges, including formulation complexity, improving bioavailability of poorly soluble compounds, and optimizing drug release profiles.

FEATURED EDITORIAL

Lonza Bets On Biologics. What's It Mean For You?

It’s a large and universally recognizable CDMO, so this matters. Swiss-based powerhouse Lonza will intensify its focus on biologics, and “advanced synthesis” such as complex modalities including antibody-drug conjugates (ADCs), cell and gene therapies (CGT), and mRNA-based therapeutics. Will other CDMOs follow suit? What does this say about the future of development outsourcing and our industry?

Scaling Up Manufacturing? Here's Why You Need A CMC Specialist

CMC experts (whether in-house or outsourced) fill a vital role during the transition from small-scale production to larger operations for maintaining quality, consistency, and compliance.

INDUSTRY INSIGHTS CONTINUED

Key Considerations For Dry Powder Inhalation

A focus on spray-drying expertise in pulmonary and nasal powder development highlights why it is vital to choose the right CDMO.

Pharmaceutical Spray Drying – Technology And Applications

Explore the transformative potential of pharmaceutical spray drying in improving drug formulation, bioavailability, and delivery through versatile and innovative applications.

Designing Shelf-Stable, Dry Powder Vaccines To Improve Global Access

Spray dry technology is being leveraged to create shelf-stable, dry-powder vaccines to treat and prevent the spread of tuberculosis which could significantly improve our global response to disease.

SPONSOR

20-minute capacity and capabilities quick-looks, 20+ brand new CDMO presenters to evaluate for best-fit this quarter – and a (virtual) commitment of less than 20 percent of your day? We're confident you don’t need 20/20 vision to see the value in this! Join us for Outsourced Pharma's July Partner Week – including sessions in Small Molecule API/HPAPI, Small Molecule Finished Dosage Form, ADC, Analytical Services, and Fill/Finish among others. Registration, on-demand access, and interactive Q&A are free.

SOLUTIONS

Internal Laboratory

Discover an analytical laboratory seamlessly integrated with manufacturing and packaging operations, which offers dependable chemical and microbiological testing that adheres to cGMP standards.

Process Development And Preclinical Manufacturing — India

The Pharma Expanse network currently spans across 9 manufacturing sites in 5 countries and can support discovery, preclinical, clinical and commercial programs for New Chemical Entities (NCEs). Pharma Expanse has an innovative business model that does not add additional costs to your project. Review our network's process development and preclinical manufacturing capabilities below and contact us to simplify your outsourcing solutions.

Upperton Pharma Solutions Capacity Update January 2025: Small Molecule

Gain insight into the capabilities of our award-winning development and manufacturing facility, which features 10 state-of-the-art GMP manufacturing suites integrated with cutting-edge R&D and QC laboratories.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: